Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
FIGS 
Figs Inc (FIGS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: FIGS (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $6.42
1 Year Target Price $6.42
| 0 | Strong Buy |
| 1 | Buy |
| 7 | Hold |
| 2 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -39.51% | Avg. Invested days 28 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.16B USD | Price to earnings Ratio 141.6 | 1Y Target Price 6.42 |
Price to earnings Ratio 141.6 | 1Y Target Price 6.42 | ||
Volume (30-day avg) 10 | Beta 1.35 | 52 Weeks Range 3.56 - 7.31 | Updated Date 09/14/2025 |
52 Weeks Range 3.56 - 7.31 | Updated Date 09/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.05 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 1.26% | Operating Margin (TTM) 6.5% |
Management Effectiveness
Return on Assets (TTM) 1.2% | Return on Equity (TTM) 1.8% |
Valuation
Trailing PE 141.6 | Forward PE 101.01 | Enterprise Value 968829284 | Price to Sales(TTM) 2.03 |
Enterprise Value 968829284 | Price to Sales(TTM) 2.03 | ||
Enterprise Value to Revenue 1.7 | Enterprise Value to EBITDA 51.38 | Shares Outstanding 154990000 | Shares Floating 149424371 |
Shares Outstanding 154990000 | Shares Floating 149424371 | ||
Percent Insiders 5.14 | Percent Institutions 94.03 |
Upturn AI SWOT
Figs Inc
Company Overview
History and Background
Figs Inc. was founded in 2013 by Heather Hasson and Trina Spear. The company revolutionized the medical apparel industry by offering stylish, comfortable, and functional scrubs directly to healthcare professionals. Figs went public in May 2021.
Core Business Areas
- Medical Apparel: Figs' primary segment focuses on designing, manufacturing, and selling medical apparel, including scrubs, lab coats, and related accessories for healthcare professionals.
Leadership and Structure
Figs Inc. is led by CEO Trina Spear. The company operates with a functional organizational structure, emphasizing design, marketing, and supply chain management.
Top Products and Market Share
Key Offerings
- Scrubs: Figs' core product is its range of scrubs, known for their comfort, durability, and stylish designs. Competitors include Med Couture, Healing Hands, and WonderWink. Figs does not publicly state scrub specific market share, they lead the direct-to-consumer segment.
- Lab Coats: Figs offers lab coats designed for style and performance. Competitors include Landau, Red Kap, and Dickies. Figs does not publicly state lab coat specific market share, they lead the direct-to-consumer segment.
- Under scrubs: Figs offers under scrub tops and bottoms. Competitors include Med Couture, Healing Hands, and WonderWink. Figs does not publicly state under scrub specific market share.
Market Dynamics
Industry Overview
The medical apparel industry is large and fragmented, with increasing demand for comfortable, durable, and stylish workwear. The industry is evolving with focus shifting to direct-to-consumer models.
Positioning
Figs is positioned as a premium direct-to-consumer brand, offering higher-quality scrubs and medical apparel compared to traditional suppliers. Their branding and direct-to-consumer model offer a competitive advantage.
Total Addressable Market (TAM)
The total addressable market is estimated to be over $12 billion. Figs is well-positioned to capture a significant portion of this market through its direct-to-consumer approach and innovative products.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Direct-to-consumer model
- High customer loyalty
- Innovative product design
- Strong online presence
Weaknesses
- Reliance on a single product category
- Higher price point compared to competitors
- Supply chain vulnerabilities
- Limited physical retail presence
Opportunities
- Expansion into new healthcare apparel categories
- International market expansion
- Partnerships with healthcare institutions
- Development of sustainable products
- Increased brand awareness through marketing
Threats
- Increased competition from established players
- Economic downturn impacting consumer spending
- Changes in healthcare regulations
- Supply chain disruptions
- Imitation products affecting brand integrity
Competitors and Market Share
Key Competitors
- ASO
- VMD
- COTY
Competitive Landscape
Figs benefits from its strong branding and direct-to-consumer approach. However, traditional apparel companies have more market share and resources. Figs must continue to innovate to maintain its competitive edge.
Growth Trajectory and Initiatives
Historical Growth: Figs has experienced rapid growth in revenue and customer base since its inception. The growth has been driven by its innovative products and direct-to-consumer model.
Future Projections: Analyst estimates project continued revenue growth for Figs, driven by expansion into new product categories and international markets.
Recent Initiatives: Figs is focusing on expanding its product offerings, improving its supply chain, and enhancing its customer experience.
Summary
Figs is a strong direct-to-consumer brand in the medical apparel industry, known for its stylish and comfortable scrubs. The company has experienced rapid growth but faces competition from established players. Figs should focus on expanding its product offerings and improving its supply chain to sustain long-term growth and continue innovating.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings
- Analyst reports
- Industry publications
- Figs Inc. Investor Relations website
Disclaimers:
This analysis is based on publicly available information and analyst estimates. The information provided is not financial advice and should not be used as the sole basis for making investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Figs Inc
Exchange NYSE | Headquaters Santa Monica, CA, United States | ||
IPO Launch date 2021-05-27 | Co-Founder, CEO & Director Ms. Catherine Eva Spear | ||
Sector Consumer Cyclical | Industry Apparel Manufacturing | Full time employees 303 | Website https://www.wearfigs.com |
Full time employees 303 | Website https://www.wearfigs.com | ||
FIGS, Inc., together with its subsidiary, FIGS Canada, Inc., operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. The company designs and sells scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings and tops, super-soft pima cotton tops, vests, fleeces, and jackets; and necessities comprising scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail stores. FIGS, Inc. was incorporated in 2013 and is headquartered in Santa Monica, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.